|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|
| Revenue | ||
| Product Revenue, Net | ||
| License Revenue | ||
| Total revenue | ||
| Operating expenses: | ||
| Cost of products sold | ||
| Research and development | ||
| General and administrative | ||
| Selling, General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income: | ||
| Interest income | ||
| Total other income | ||
| Net loss | ||
| Net loss per share attributable to common stockholders—basic and diluted | ||
| Weighted average common shares outstanding—basic and diluted | ||
| Other comprehensive income | ||
| Unrealized gains on marketable securities, net | ||
| Total other comprehensive income | ||
| Total comprehensive loss |
Loading...
